Riskpilot← Back to searchSign inGet full accessRöda Kvarn Bio Sverige AB
ABDissolvedOrg 5564005840Repair of communication equipment · NACE 9512Est. 19902 employees
Revenue 2023
SEK 3,6M
-14% vs 2022
EBITDA margin
138.0%
+309% vs 2022
Equity ratio
82.9%
Financial strength
Net profit 2023
SEK 4,2M
+630% vs 2022
| Revenue | SEK 3,6M | -14% |
| EBITDA | SEK 4,9M | +309% |
| Net profit | SEK 4,2M | +630% |
| Total assets | SEK 7M | +86% |
| Equity | SEK 5,8M | +265% |
| Employees | 2 | — |
Legal name
Röda Kvarn Bio Sverige AB
Org number
5564005840
Legal form
Aktiebolag
NACE code
9512 · Repair of communication equipment
Founded
6 augusti 1990
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva biografverksamhet ävensom idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 6 610 | 4 905 | 573 | 4 138 | 3 557 |
| Staff expenses | — | — | — | −1 400 | −832 |
| EBITDA | 286 | 269 | 478 | 1 201 | 4 910 |
| Depreciation & amort. | −178 | −172 | −174 | −171 | −116 |
| EBIT | 108 | 97 | 304 | 1 030 | 4 793 |
| Net financials | −71 | −51 | −57 | −32 | −25 |
| Profit before tax | 54 | 36 | 185 | 735 | 5 341 |
| Tax | −14 | −8 | −40 | −155 | −1 108 |
| Net profit | 40 | 28 | 145 | 580 | 4 233 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 3 215 | 2 974 | 3 409 | 3 776 | 7 032 |
| Equity | 943 | 872 | 1 017 | 1 597 | 5 830 |
| Long-term debt | 750 | 750 | 750 | 550 | 0 |
| Short-term debt | 1 282 | 1 104 | 1 332 | 1 056 | 1 202 |
| Total debt | 2 032 | 1 854 | 2 082 | 1 606 | 1 202 |
EBITDA margin
138.0%
This company
15.8%
Market median
+773% vs market
20192023
Equity ratio
82.9%
This company
38.2%
Market median
+117% vs market
20192023
Return on equity
72.6%
This company
18.4%
Market median
+295% vs market
20192023
Net profit margin
119.0%
This company
8.1%
Market median
+1369% vs market
20192023
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20192023
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MW Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Röda Kvarn Bio Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marcus Wallentin Torstensson | Chief Auditor | 0 companies |
| Karl Peter Fornstam | Board of Directors | 0 companies |
| John Peter Hedlund | Deputy Board Member | 0 companies |